259
Views
3
CrossRef citations to date
0
Altmetric
CASE SERIES

Bloodstream Infections Caused by Drug Resistant Ralstonia species: A Case Series During the COVID-19 Pandemic

ORCID Icon
Pages 1339-1344 | Received 17 Jan 2023, Accepted 02 Mar 2023, Published online: 09 Mar 2023

References

  • Santella B, Folliero V, Pirofalo GM, et al. Sepsis-A retrospective cohort study of bloodstream infections. Antibiotics. 2020;9(12):851. PMID: 33260698. doi:10.3390/antibiotics9120851
  • Patolia S, Abate G, Patel N, Patolia S, Frey S. Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia. Ther Adv Infect Dis. 2018;5(1):11–18. PMID: 29344356. doi:10.1177/2049936117727497
  • Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49(2):760–766. PMID: 15673761. doi:10.1128/AAC.49.2.760-766.2005
  • Gikas A, Samonis G, Christidou A, et al. Gram-negative bacteremia in non-neutropenic patients: a 3-year review. Infection. 1998;26(3):155–159. PMID: 9646106. doi:10.1007/BF02771841
  • Basso M, Venditti C, Raponi G, et al. A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit. Infect Drug Resist. 2019;12:2391–2395. PMID: 31447567. doi:10.2147/IDR.S206492
  • Degand N, Carbonnelle E, Dauphin B, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting Gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol. 2008;46(10):3361–3367. PMID: 18685005. doi:10.1128/JCM.00569-08
  • Liu J, Peters BM, Yang L, et al. Antimicrobial treatment on a catheter-related bloodstream infection (CRBSI) case due to transition of a multi-drug-resistant ralstonia mannitolilytica from commensal to pathogen during hospitalization. Antibiotics. 2022;11(10):1376. PMID: 36290034. doi:10.3390/antibiotics11101376
  • Said M, van Hougenhouck-Tulleken W, Naidoo R, Mbelle N, Ismail F. Outbreak of Ralstonia mannitolilytica bacteraemia in patients undergoing haemodialysis at a tertiary hospital in Pretoria, South Africa. Antimicrob Resist Infect Control. 2020;9(1):117. PMID: 32727576. doi:10.1186/s13756-020-00778-7
  • Ryan MP, Adley CC. Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis. 2014;33(3):291–304. PMID: 24057141. doi:10.1007/s10096-013-1975-9
  • Kirkgöz E, Zer Y. Clonal comparison of Acinetobacter strains isolated from intensive care patients and the intensive care unit environment. Turk J Med Sci. 2014;44(4):643–648. PMID: 25551936. doi:10.3906/sag-1304-126
  • Church DL, Cerutti L, Gürtler A, Griener T, Zelazny A, Emler S. Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. Clin Microbiol Rev. 2020;33(4):e00053–19. PMID: 32907806. doi:10.1128/CMR.00053-19
  • Coenye T, Vandamme P, LiPuma JJ. Infection by ralstonia species in cystic fibrosis patients: identification of r. pickettii and r. mannitolilytica by polymerase chain reaction. Emerg Infect Dis. 2002;8(7):692–696. PMID: 12095436. doi:10.3201/eid0807.010472
  • Fernández-Olmos A, García-Castillo M, Morosini MI, Lamas A, Máiz L, Cantón R. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros. 2012;11(1):59–62. PMID: 21968086. doi:10.1016/j.jcf.2011.09.001
  • Gales AC, Jones RN, Andrade SS, Sader HS. Antimicrobial susceptibility patterns of unusual nonfermentative Gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997–2002). Mem Inst Oswaldo Cruz. 2005;100(6):571–577. PMID: 16302068. doi:10.1590/s0074-02762005000600011
  • Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents. 2005;25(2):95–109. PMID: 15664479. doi:10.1016/j.ijantimicag.2004.10.002
  • Girlich D, Naas T, Nordmann P. OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D β-lactamase from Ralstonia pickettii. Antimicrob Agents Chemother. 2004;48(11):4217–4225. PMID: 15504844. doi:10.1128/AAC.48.11.4217-4225.2004
  • Batarilo I, Maravic-Vlahovicek G, Bedenic B, et al. Oxacillinases and antimicrobial susceptibility of Ralstonia pickettii from pharmaceutical water systems in Croatia. Lett Appl Microbiol. 2022;75(1):103–113. PMID: 35352370. doi:10.1111/lam.13711
  • Labarca JA, Trick WE, Peterson CL, et al. A multistate nosocomial outbreak of Ralstonia pickettii colonization associated with an intrinsically contaminated respiratory care solution. Clin Infect Dis. 1999;29(5):1281–1286. PMID: 10524976. doi:10.1086/313458
  • Thet M, Pelobello MLF, Das M, et al. Outbreak of nonfermentative Gram-negative bacteria (Ralstonia pickettii and Stenotrophomonas maltophilia) in a hemodialysis center. Hemodial Int. 2019;23(3):E83–E89. PMID: 30746829. doi:10.1111/hdi.12722